Allogenic hematopoietic stem cell transplantation (allo-HSCT) is an effective treatment for patients with hematologic malignancy and nonmalignant disease. Non-relapse mortality (NRM) may compromise ...
We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results